Psychometric properties of Structured Clinical Interview for DSM-5 Disorders-Clinician Version (SCID-5-CV).
psychiatric disorders
reliability
validity
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
17
08
2020
received:
08
02
2020
accepted:
18
09
2020
pubmed:
18
3
2021
medline:
1
7
2021
entrez:
17
3
2021
Statut:
ppublish
Résumé
The purpose of this study was to evaluate the psychometric properties of Structured Clinical Interview Version for DSM-5 (R) Clinical Version (SCID-5-CV) in a population of patients with psychiatric disorders in Tehran. The study population included all outpatients and inpatients referred to three psychiatric centers in Tehran, namely Iran Psychiatric Hospital, Rasoul Akram Hospital, and Clinic of Behavioral Sciences and Mental Health (Tehran Psychiatric Institute). Inclusion criteria included age between 16 and 70 years, informed consent to study, ability to understand and speak Persian, and no specific physical problems that interfere with the conduct of the interview. Also, exclusion criteria included inability to communicate, mental retardation or dementia, severe symptoms of acute psychosis, and severe restlessness. In addition to demographic questionnaire, Persian version of SCID-5-CV was used in this study. Finally, diagnostic validity, test-retest reliability, and inter-rater reliability were used to evaluate the information. In terms of the kappa criterion, for all diagnoses except for anxiety disorders, kappa was above 0.4 as a result of agreement above average, but in anxiety disorders with kappa 0.34 there was a moderate agreement between psychiatrist and SCID interviewer reports. Also, according to the psychiatrist's diagnosis as the gold standard, in most diagnoses, except for anxiety disorders, kappa was higher than 0.80, indicating the desirable characteristic of this tool in the diagnosis of disorders. Sensitivity of all diagnoses was higher than 0.80. According to the findings of the present study, SCID-5-CV can be used for diagnostic purposes in psychiatric clinics and hospitals and to evaluate the treatment process of patients. In general, this version is suitable especially the schizophrenia spectrum and other psychiatric disorders; however, using SCID-5-CV for anxiety-related disorders should be done with caution.
Identifiants
pubmed: 33729681
doi: 10.1002/brb3.1894
pmc: PMC8119811
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e01894Informations de copyright
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
Clin Psychol Psychother. 2011 Jan-Feb;18(1):75-9
pubmed: 20309842
Compr Psychiatry. 2001 Sep-Oct;42(5):369-74
pubmed: 11559863
Compr Psychiatry. 2009 Jan-Feb;50(1):86-91
pubmed: 19059520
Assessment. 2018 Jan;25(1):3-13
pubmed: 26988404
Acta Psychiatr Scand. 1991 Aug;84(2):167-73
pubmed: 1950612
Arch Gen Psychiatry. 1992 Aug;49(8):630-6
pubmed: 1637253
Brain Behav. 2021 May;11(5):e01894
pubmed: 33729681
J Pers Disord. 2000 Winter;14(4):291-9
pubmed: 11213787
Am J Psychiatry. 2004 Jul;161(7):1231-7
pubmed: 15229056
Arch Gen Psychiatry. 1992 Aug;49(8):624-9
pubmed: 1637252
Int J Methods Psychiatr Res. 2018 Mar;27(1):
pubmed: 29034525
Drug Alcohol Depend. 2000 May 1;59(2):173-6
pubmed: 10891630
J Nerv Ment Dis. 1995 Jun;183(6):365-9
pubmed: 7798084